Table 1.
5MP1 mRNA expression and clinicopathological factors in CRC patients.
| Factors | 5MP1 High (N = 56) | 5MP1 Low (N = 66) | P-Value |
|---|---|---|---|
| Age | 0.438 | ||
| <65 | 19 | 18 | |
| ≧65 | 37 | 48 | |
| Gender | 0.581 | ||
| Male | 36 | 39 | |
| Female | 20 | 27 | |
| Histology | 0.752 | ||
| Well or moderately differentiated | 52 | 60 | |
| Poorly differentiated | 4 | 6 | |
| Depth of invasion | 0.141 | ||
| M, SM, MP | 10 | 20 | |
| SS, SE, SI | 46 | 46 | |
| Lymph node metastasis | 0.856 | ||
| Absent | 29 | 36 | |
| Present | 27 | 30 | |
| Lymphatic invasion | 1.000 | ||
| Absent | 32 | 37 | |
| Present | 24 | 29 | |
| Venous invasion | 0.034⁎ | ||
| Absent | 32 | 50 | |
| Present | 24 | 16 | |
| Distant metastasis | 0.018⁎ | ||
| Absent | 51 | 66 | |
| Present | 5 | 0 | |
| UICC TNM stage | 1.000 | ||
| I/II | 29 | 35 | |
| III/IV | 27 | 31 |
M, mucosa; SM, submucosa; MP, muscular propria; SS, subserosa; SE, serosal invasion; SI, invasion to adjacent organs; UICC TNM stage, Union for International Cancer Control tumor-node-metastasis stage.
⁎
Statistically significant.